Evidence map›Paper›PMID 16463009›Full record

ArticlePharmaceutical research2006

Hydrophilic absorbable copolyester exhibiting zero-order drug release.

Sasa Andjelić, Jenny Yuan, Dennis D Jamiolkowski, Robert Diluccio, Rao Bezwada, Hua Zhang, Jovan Mijović

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Design and Synthesis of Fast-Degrading Poly(anhydride-esters).Macromolecular rapid communications · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sasa AndjelićProcedural Implants R&D, Ethicon, a Johnson & Johnson Company, Route 22 West, Somerville, New Jersey 08876-0151, USA. sandjeli@ethus.jnj.com
Jenny Yuan
Dennis D Jamiolkowski
Robert Diluccio
Rao Bezwada
Hua Zhang
Jovan Mijović
Johnson & Johnson (United States) · USNew York University · USBezwada Biomedical (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA novel absorbable hydrophilic copolyester developed in our laboratory, amorphous 40/60 poly(ethylene diglycolate-co-glycolide), exhibits outstanding physical properties. Films made from this material appear fully transparent, colorless, soft and slightly elastic, but relatively strong and durable materials so that they can be potentially used as stand-alone devices in various in-vivo medical applications. In this study, in-vitro drug release characteristics of this copolyester were examined.

methodsHigh Performance Liquid Chromatography was used to generate release profiles on selected non-steroidal anti-inflammatory agents, NSAIDs. In addition, dielectric relaxation spectroscopy, as well as mid- and near infrared spectroscopy, were used to study specific polymer chain interactions in water and buffer solution as a function of aging time at 37 degrees C.

resultsThis copolyester, compression molded into a film, exhibited nearly constant in-vitro release of various hydrophilic and hydrophobic drugs. The release profile showed minimal or, in most cases, no burst effect. The effect was observed with the three NSAIDs that were tested as model compounds; however, this system may prove generally useful for other drug entities. In-vitro hydrolysis conducted at 37 degrees C on this hydrophilic copolyester revealed an unusually long induction period (no hydrolysis for up to 6 days), followed by the relatively rapid hydrolysis. Data from dipole relaxation spectroscopy indicated that the water molecules do not structurally associate with the polymer chains in phosphate buffer during initial hydrolysis period.

conclusionsThe results suggest unique dynamics of water diffusion through the polymer matrix that may play a critical role in achieving controlled release properties. Furthermore, we suspect that the molecular interactions associated with this new synthetic absorbable material may find a critical utility in important medical applications.

Indexed as

AbsorptionAnti-Inflammatory Agents, Non-SteroidalDelayed-Action PreparationsDiclofenacExcipientsHydrolysisIndicators and ReagentsIndomethacinKetoprofenLactic AcidLactonesPolyethylenesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymersSpectroscopy, Fourier Transform InfraredAnti-Inflammatory Agents, Non-SteroidalDelayed-Action PreparationsDiclofenacExcipientsIndicators and ReagentsIndomethacinKetoprofenLactic AcidLactonespoly(ethylene diglycolate-co-glycolide)PolyethylenesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymersWater

Identifiers

PMID16463009
OpenAlexW1992693586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.